5 completed, 2 unknown. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 5, Unknown 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Fosfomycin: new trials by email Literature Review of Fosfomycin trials Research Report on Fosfomycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI Prevention Fosfomycin 3000 MG, Levofloxacin 500mg - Urological System Complication of Procedure, Urinary Tract Infections | Phase 1 / Phase 2 | Completed | Universitas Indonesia | 126 | 2022-12-30 | 2024-10-09 |
| GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery GM-CSF, fosfomycin and metronidazole - Pouchitis | Phase 1 / Phase 2 | Unknown | Zealand University Hospital | 18 | 2021-09-06 | 2023-01-26 |
| PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age) ZTI-01 100 mg/kg, ZTI-01 75 mg/kg - Pediatric ALL | Phase 1 | Unknown | Nabriva Therapeutics AG | 21 | 2018-05-24 | 2023-09-15 |
| 4-way Crossover QT Evaluation in Healthy Subjects ZTI-01, Moxifloxacin 400mg, Placebo IV - Cardiac Repolarization in Healthy Subjects | Phase 1 | Completed | Nabriva Therapeutics AG | 41 | 2018-01-11 | 2019-03-06 |
| Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers amikacin/fosfomycin - Healthy | Phase 1 | Completed | Cardeas Pharma | 30 | 2016-04-01 | 2016-07-11 |
| PK/PD and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adults Fosfomycin - Healthy Subjects | Phase 1 | Completed | Vance Fowler, M.D. | 19 | 2016-01-01 | 2019-07-30 |
| Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and MonurolĀ® in Healthy Subjects Fosfomycin tromethamine, Fosfomycin disodium - Pseudomonas Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2014-08-01 | 2016-04-04 |
Pouchitis (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Pseudomonas Infections (1) · Urinary Tract Infections (1)
Nabriva Therapeutics AG (2) · Cardeas Pharma (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Universitas Indonesia (1) · Vance Fowler, M.D. (1) · Zealand University Hospital (1)
United States (5) · Denmark (1) · Indonesia (1)
Evelyn J Ellis-Grosse, PhD (1) · Harrina E Rahardjo, Professor (1) · Jennifer Schranz, MD (1) · John S Bradley, MD (1) · Vance Fowler, MD (1)
PMID 29891606, PMID 31767717, PMID 40660169, PMID 42728546
1UM1AI104681-01 (1)